Piotr Tymoszuk Selected Research

Piotr Tymoszuk Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 12/2010
11	Infections 11/2023 - 01/2017
10	Inflammation (Inflammations) 10/2023 - 03/2012
8	Anemia 01/2023 - 01/2016
7	COVID-19 11/2023 - 01/2021
5	Salmonella Infections (Salmonellosis) 09/2021 - 01/2017
4	Iron Deficiencies 01/2023 - 01/2018
4	Sepsis (Septicemia) 01/2021 - 04/2011
3	Iron Overload 01/2020 - 01/2017
2	Carcinoma (Carcinomatosis) 01/2023 - 01/2020
2	Disease Progression 09/2021 - 01/2018
2	Communicable Diseases (Infectious Diseases) 09/2021 - 07/2018
2	Necrosis 01/2021 - 07/2018
2	Hemochromatosis (Bronze Diabetes) 10/2020 - 01/2017
2	Atherosclerosis 10/2020 - 01/2015
2	Chronic Disease (Chronic Diseases) 01/2020 - 01/2017
2	Breast Neoplasms (Breast Cancer) 04/2014 - 10/2013
1	Testicular Germ Cell Tumor 01/2023
1	Arthritis (Polyarthritis) 01/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2023
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2023
1	Seminoma 01/2023
1	Neoplasm Metastasis (Metastasis) 11/2022
1	Adenocarcinoma 11/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2022
1	Lung Injury 01/2022
1	Bacterial Infections (Bacterial Infection) 09/2021
1	Persistent Infection 01/2021
1	Cytokine Release Syndrome 01/2021
1	Acute Lung Injury 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Human Influenza (Influenza) 01/2021
1	Chronic Renal Insufficiency 01/2020
1	Crohn Disease (Crohn's Disease) 01/2020
1	Enteritis 01/2020
1	Multiple Sclerosis 10/2019
1	Restless Legs Syndrome (Restless Legs) 01/2019
1	Critical Illness (Critically Ill) 01/2019

Drug/Important Bio-Agent (IBA)

19	IronIBA 01/2023 - 01/2016
7	Messenger RNA (mRNA)IBA 01/2023 - 12/2010
5	HepcidinsIBA 10/2019 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 11/2023 - 12/2010
4	CytokinesIBA 09/2021 - 01/2021
3	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2023 - 12/2010
3	LipidsIBA 01/2021 - 01/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 10/2013
2	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 10/2023 - 01/2021
2	CatecholaminesIBA 10/2023 - 01/2019
2	Interferon-gamma (Interferon, gamma)IBA 10/2023 - 01/2021
2	Dopamine (Intropin)FDA LinkGeneric 10/2023 - 01/2019
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 10/2023 - 05/2022
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2023 - 01/2023
2	EnzymesIBA 01/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	Dietary IronIBA 01/2021 - 01/2017
2	Apolipoproteins E (ApoE)IBA 10/2020 - 01/2015
2	Erythropoietin FDA Link 01/2020 - 01/2017
2	Hormones (Hormone)IBA 07/2018 - 01/2018
2	Lapatinib (GW572016)FDA Link 12/2013 - 10/2013
1	Interferon Type IIBA 11/2023
1	KynurenineIBA 10/2023
1	Serotonin (5 Hydroxytryptamine)IBA 10/2023
1	dopamine 3-O-sulfateIBA 10/2023
1	Polysaccharides (Glycans)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2023
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2023
1	Peptidoglycan (Murein)IBA 01/2023
1	ChemokinesIBA 01/2023
1	Chemokine ReceptorsIBA 11/2022
1	COVID-19 VaccinesIBA 03/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 09/2021
1	CollagenIBA 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	ApoferritinsIBA 01/2021
1	InflammasomesIBA 01/2021
1	LipoxinsIBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	CB-1158IBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	oxidized low density lipoproteinIBA 10/2020
1	LDL CholesterolIBA 10/2020
1	CholesterolIBA 10/2020
1	UbiquitinIBA 02/2020
1	Cullin Proteins (Cullins)IBA 02/2020
1	Ligases (Synthetase)IBA 02/2020
1	Therapeutic UsesIBA 01/2020
1	Transferrin (beta 2 Transferrin)IBA 01/2020
1	Darbepoetin alfa (Aranesp)FDA Link 01/2020
1	Iron Regulatory Protein 2IBA 01/2019
1	Aconitate Hydratase (Aconitase)IBA 01/2019
1	Superoxides (Superoxide)IBA 01/2019
1	Dopamine Agents (Dopaminergic Agents)IBA 01/2019

Therapy/Procedure

11	Therapeutics 11/2023 - 10/2013
2	Aftercare (After-Treatment) 01/2022 - 10/2013
2	Drug Therapy (Chemotherapy) 01/2020 - 12/2013
1	Immunotherapy 01/2020